Ocugen to Present at April 2026 Investor and Industry Conferences
Ocugen, Inc., a biotechnology company focusing on gene therapies for blindness diseases, announced that its executives will present at two prominent biotech conferences in April 2026. The presentations will cover their novel modifier gene therapy platform and near-term catalysts, including the planned Biologics License Application (BLA) submission …